MYELOPATHY

Clinical trials for MYELOPATHY explained in plain language.

Never miss a new study

Get alerted when new MYELOPATHY trials appear

Sign up with your email to follow new studies for MYELOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug may supercharge walking recovery after spinal cord injury

Disease control Not yet recruiting

This study tests whether a drug called istradefylline can make walking therapy more effective for people with chronic, incomplete spinal cord injury. The therapy uses brief low-oxygen breathing to spark nerve growth, but a natural chemical called adenosine may limit its benefits.…

Matched conditions: MYELOPATHY

Phase: PHASE1, PHASE2 • Sponsor: Randy Trumbower, PT, PhD • Aim: Disease control

Last updated Apr 26, 2026 19:37 UTC

MYELOPATHY

Get alerted when new MYELOPATHY trials appear

New drug may supercharge walking recovery after spinal cord injury